Bionano Genomics Inc (BNGO) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Bionano Genomics Inc   (NASDAQ: BNGO)


Bionano Genomics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Bionano Genomics Inc's ROI in the second quarter of 2026?
Bionano Genomics Inc recorded a cumulative net loss of $-32 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -68.48%.

Within the Healthcare sector 139 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3344 to 3742.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -4.92 % -15.05 % -26.23 % -41.78 % -54 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 38 44 51 56 52
Return On Investment (TTM) -68.48 % -62.52 % -50.14 % -77.46 % -150.48 %
BNGO's Overall Ranking # 3742 # 3344 # 3296 # 3659 # 3414
Seq. Investment Change TTM -7.06 % -4 % 5.68 % 0.85 % -16.96 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -32 -32 -26 -39 -74




Return On Investment BNGO's Ranking
Within: No.
Industry # 10
Sector # 140
Overall # 3742

Return On Investment Statistics
High Average Low
-20.39 %
-139.57 %
-684.31 %
(Dec 31 2021)   (Jun 30 2020)







Financial Statements
Bionano Genomics Inc's II. Quarter Investments $ 38 Millions BNGO's Balance sheet
Bionano Genomics Inc's II. Quarter Income $ -7 Millions Quarterly BNGO's Income Statement
BNGO's Income by Division See BNGO's Income by Division


BNGO Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 51 39 96 272 355
Y / Y Investment Growth 28.77 % -59.1 % -64.6 % -23.54 % 589.75 %
Net Income in Millions -26 -112 -232 -133 -72
Y / Y Net Income Growth - - - - -
Annual Return On Investment -52.12 % -284.84 % -241.78 % -48.82 % -20.39 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Laboratory Analytical Instruments Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BNGO's Roi Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BNGO's Competitors
Subscribers only: Roi for Bionano Genomics Inc's Suppliers
Subscribers only: Return On Investment for BNGO's Customers

Other Ratios
BNGO's Roa BNGO's Inventory Turnover Ratio BNGO's Growth Rates BNGO's Dividend Statistics
BNGO's Profitability Ratios BNGO's Asset Turnover Ratio BNGO's Dividend Growth
BNGO's Roe BNGO's Valuation Ratios BNGO's Financial Strength Ratios BNGO's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI


Date modified: 2026-08-12T19:45:07+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.